Summary:

This study utilized an AI-driven data analysis model to identify Key Active Pharmaceutical Ingredients within our lead pipeline, MT101. These Ingredients were found to effectively inhibit α-synuclein aggregation while simultaneously activating the Proteasome.

Publication Details:

• Journal: Biomedicine & Pharmacotherapy (2026)

• Title: De novo identification of potent ingredients for proteasome activation in MT101-5 using an AI-driven approach

• DOI: https://doi.org/10.1016/j.biopha.2026.11909